美股A股
StockGist
Back
8-K2026-05-14· grok-4-1-fast-non-reasoning

MTNE · CH4 Natural Solutions Corporation

0001193125-26-224328

SEC filing

Summary

CH4 Natural Solutions Corporation completed its IPO of 20 million units and partial exercise of the over-allotment option for 2 million additional units, depositing $220 million in trust.

Key takeaways

Full analysis

CH4 Natural Solutions Corporation, a special purpose acquisition company (SPAC), finalized key capital-raising events post-IPO. On May 4, 2026, it closed its IPO of 20 million units at $10 each, each comprising one Class A ordinary share (par $0.0001) and half a warrant exercisable at $11.50 per share, yielding $200 million gross. Concurrently, a private placement of 200,000 units to its sponsor entity added $2 million. The underwriter's partial exercise of the 45-day over-allotment option on May 6, with closing on May 8, brought in 2 million more units for $20 million gross, with 1 million units remaining available. Net proceeds totaling $220 million, inclusive of $6.6 million deferred underwriting and advisory fees (3% each on over-allotment), were fully deposited into a trust account at Continental Stock Transfer & Trust Company, ensuring funds for a business combination. The pro forma unaudited balance sheet as of May 8 reflects this, with $220 million in trust, minimal cash ($1.66 million), and liabilities including $6.6 million deferred fees each for underwriting and advisory, plus a reduced over-allotment liability after write-off. Shareholders' deficit stands at approximately $13.8 million post-adjustments for accretion and fees. This structure positions the SPAC with substantial dry powder for de-SPAC transactions while highlighting typical SPAC economics like sponsor promote via Class B shares and fee deferrals.